BOPU

CytoCan Corp. is a biotechnology company dedicated to the research and development of innovative cancer therapies. The company specializes in creating multi-specific fusion protein drugs through its modular platform technology, which enables the production of proteins that target cancer cells with multiple functions. By identifying unmet medical needs and focusing on difficult-to-treat cancers, CytoCan designs targeted immune therapies aimed at enhancing patients' ability to combat cancer. Through its advanced approach, the company seeks to make significant contributions to the field of oncology and improve treatment outcomes for patients facing challenging cancer diagnoses.

Kula Bio, Inc. is focused on developing innovative biological solutions for modern agriculture. Founded in 2018 and based in Somerville, Massachusetts, the company specializes in the production of organic biofertilizers using nitrogen-fixing microbes charged with renewable energy. By enhancing natural microbial processes, Kula Bio aims to create affordable and sustainable fertilization methods that enable farmers to increase their yields while promoting environmental stewardship. The company's approach seeks to disrupt traditional synthetic fertilizers, bridging the gap between effective agricultural practices and the responsible management of natural resources.

Kula Bio, Inc. is focused on developing innovative biological solutions for modern agriculture. Founded in 2018 and based in Somerville, Massachusetts, the company specializes in the production of organic biofertilizers using nitrogen-fixing microbes charged with renewable energy. By enhancing natural microbial processes, Kula Bio aims to create affordable and sustainable fertilization methods that enable farmers to increase their yields while promoting environmental stewardship. The company's approach seeks to disrupt traditional synthetic fertilizers, bridging the gap between effective agricultural practices and the responsible management of natural resources.